Compare AURA & ALOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | ALOY |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 797.5M | 862.3M |
| IPO Year | 2021 | 2021 |
| Metric | AURA | ALOY |
|---|---|---|
| Price | $6.04 | $8.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $16.60 | ★ $17.00 |
| AVG Volume (30 Days) | 648.1K | ★ 1.6M |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $692,803.00 |
| Revenue This Year | N/A | $258.37 |
| Revenue Next Year | N/A | $926.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.73 | $6.83 |
| 52 Week High | $9.54 | $26.90 |
| Indicator | AURA | ALOY |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 39.43 |
| Support Level | $6.05 | $7.89 |
| Resistance Level | $6.27 | $9.42 |
| Average True Range (ATR) | 0.29 | 0.45 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 24.38 | 14.77 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
REalloys Inc is a development-stage company building a North American integrated rare earth to high-performance neodymium iron boron (NdFeB) magnet materials and magnet supply chain focused on meeting the demands of the protected markets of the United States, which includes the U.S. National Defense Stockpiles (NDS), Defense Industrial Base (DIB), Nuclear Industrial Base (NIB), robotics, electric aviation, and critical infrastructure industries. The company operates in a single, integrated rare-earth development and supply chain enterprise focused on building a North American mine-to-magnet supply chain for U.S. Protected Markets.